For instance, the MPS1 subtype, characterized by upregulated lipid metabolism, can be targeted with FASN inhibitors to block fatty acid synthesis, reducing tumor cell energy supply and membrane lipid production, thereby inhibiting tumor growth. Here, FASN is linked to neoplasm.